MC38-Stk11 KO

Export PDF

Strain Information

Validation Data

1723183394164.png

Fig1. Stk11 expression on in vitro cultured cells of MC38-Stk11-KO.

2f865c01c62c73bfe8e45793fe742f0.png

Fig2. In vivo validation of MC38-Stk11-KO in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-Stk11-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 3rd day after vaccination, twice a week.

447454c91f7cf64f5a0621e71a67f38.png

Fig3. In vivo validation of MC38-Stk11-KO in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-Stk11-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 3rd day after vaccination, twice a week.

fbc061c9663ba11cd5d2f79c7ce2a9e.png

Fig4. Stk11 expression in tumors after in vivo growth of MC38-Stk11-KO in wild type C57BL/6 mice. When the mean tumor volume (MTV) reaches 500-800 mm3, take one tube from each group and send it to Western Blot for testing (Markers: mGapdh, mStk11); When the MTV reaches 1000-1500mm3, take 2 tubes from each group and send them to Western Blot for testing (Markers: mGapdh, mStk11). A, the MTV reaches 800 mm3B, the MTV reaches 1500 mm3.


Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

Learn more